Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03639324
Brief Title: Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL (RIVe-CLL)

First Submitted : August 8, 2018
First Submitted that Met QC Criteria : August 16, 2018
First Posted : August 21, 2018

Last Update Submitted that Met QC Criteria : October 15, 2019
Last Update Posted : October 16, 2019